Migraine and the development of additional psychiatric and pain disorders in the transition from adolescence to adulthood by Gerstl, Lucia et al.
Original Article
Migraine and the development of
additional psychiatric and pain disorders
in the transition from adolescence to
adulthood
Lucia Gerstl1,*, Natalie Tadych1,*, Florian Heinen1,
Christine Kainz1, Michaela V Bonfert1, Iris Hannibal1,
Kristina Huss1, Ruth Ruscheweyh2 , Andreas Straube2,
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Abstract
Introduction: The transition from childhood to adolescence and from adolescence to adulthood are vulnerable phases
in life. In these phases, late or insufficient treatment of diseases may lead to chronification and favor development of
additional disorders. In adolescents, migraine often has a highly negative impact on school performance and everyday life.
The hypothesis of the present study was that adolescents with migraine have a higher risk for developing additional
disorders such as psychiatric disorders or other pain syndromes in the course of the disease.
Materials and methods: In this study, we analyzed health insurance data of 56,597 German adolescents at the age of
15 years in the year 2006. By using the International Classification of Diseases (ICD 10), we determined a group with
migraine diagnosis in the year 2006 and a control group without any headache diagnosis in 2006. We then compared
both groups regarding the development of additional disorders (based on the ICD 10) during the following 10 years
(2007 to 2016).
Results: Adolescents with migraine had a 2.1 fold higher risk than persons without migraine diagnosis to develop an
additional affective or mood disorder, a 1.8 fold higher risk to obtain neurotic, stress-related and somatoform disorders,
a 1.8 fold higher risk to subsequently suffer from behavioral syndromes, a 1.6 higher risk to get back pain and a 1.5 fold
higher risk for irritable bowel syndrome during the next 10 years.
Conclusion: Adolescents with migraine are at risk for developing additional disorders later. Considering and addressing
the patient’s risks and potential medical and psychosocial problems might improve the long-term outcome significantly.
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Introduction
Headache is a major health problem due to its high
impact on quality of life and impairment of social
life, school and work (1). No matter what ethnicity,
sex, age or social background, headache is a disorder
known worldwide. The worldwide prevalence of cur-
rent headache disorders in adults is around 46% (2),
the prevalence in children is approximately 58% (3).
Migraine is among the 10 most disabling diseases
worldwide (3,4) with an approximate prevalence of
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11% in adults (2) and 10% in adolescents (5).
The transition from adolescence to young adulthood
is a sensitive developmental period with many chal-
lenges regarding independency, choice of profession,
partnerships etc. (6). The possibly resulting higher
stress level negatively contributes to migraine (5).
Several studies investigated the co-occurrence of pri-
mary headache and other medical conditions (7–11).
Milde-Busch et al. reported a co-occurrence of psycho-
pathological symptoms (e.g. emotional symptoms and
hyperactivity) in adolescents with headache (9). Those
patients presented three times more with psychopatho-
logical symptoms. The authors discussed that the co-
occurrence of psychopathological symptoms might
vary with the type of headache. This might be a rele-
vant aspect for future studies (9). Wang et al. described
that 47% of adolescents with chronic daily headache
presented with at least one psychiatric comorbidity,
mostly major depression and panic disorder (10). A
publication of Pavone et al. showed that children
with primary headaches, especially with migraine,
often had an association with asthma, allergic disor-
ders, sleep disorders and behavioral disorders (11).
Regarding the specificity of risk factors for headaches
and the correlation between headaches in adolescents
and other medical conditions or symptoms, Lehmann
et al. reported a higher association in adolescents with
headaches and the concurrent existence of other med-
ical complaints and symptoms such as additional
abdominal or musculoskeletal pain or psychological
symptoms (7). A study from 2014 by Blaschek et al.
investigated the association between shoulder/neck
pain in adolescents with migraine and tension type
headache (TTH) and could display a significant asso-
ciation between those conditions. This study highlight-
ed the importance of the impact of muscular pain for
patients with TTH but, as a new finding, also for
patients with migraine (8). These previous studies
therefore reveal a co-occurrence of other medical con-
ditions in patients with headache, but neglect the aspect
of chronological order or suspected causation. Breslau
et al. however described that migraine increases the risk
of depression and vice versa in adults (12).
The aim of this study was to investigate if adoles-
cents diagnosed with migraine have a significantly
higher risk for developing psychiatric comorbidities
and pain syndromes during a 10 year time span com-
pared to persons without any headache diagnosis. All
diagnoses were based on ICD 10. The comorbidities,
previously described in the literature and evaluated in
this study are mood disorders, neurotic, stress-related
and somatoform disorders, behavioral syndromes asso-
ciated with physiological disturbances and physical fac-
tors, irritable bowel syndrome and back pain (7–11).
Materials and methods
Data acquisition
The dataset of a German general health insurance com-
pany (BARMER) covering the period of 2006 to 2016
was analyzed in this secondary data analysis. The
BARMER is one of the German statutory insurance
companies, serving around 11% of the German popu-
lation. In Germany, all physicians have to code their
diagnoses according to the International Classification
of Diseases version 10 (ICD-10). For the present retro-
spective cohort study, we included all BARMER
insured persons who were aged 15 years in 2006 and
were continuously insured with the BARMER between
2006 and 2016 (i.e. between their 15th and their 25th
year of age), resulting in a cohort of n¼ 56,597.
Two groups were defined to evaluate differences
regarding psychiatric and pain disorders (see
Figure 1; for description of used ICD 10 diagnoses
see Supplemental Materials 1):
Group 1 (migraine group¼ exposed group): Patients
with a diagnosis of migraine (G43.-) in 2006 and at
least three further G43.- diagnoses but no G44.- or
R51 diagnoses between 2006 and 2016) and without
any of the analyzed comorbidities (see below) in the
index year 2006 (n¼ 431). We claimed four instances
of diagnosis of migraine during the 10 year observation
period to guarantee a sufficiently accurate diagnosis. If
the diagnosis of migraine was made only one to three
times we suspected a false diagnosis as migraine typi-
cally does not totally disappear.
Group 2 (control group): Patients without any head-
ache diagnosis (G43.x, G44.x, R51 corresponding to
migraine, tension-type headache, unspecific headache,
and other headache disorders) and without any of the
analyzed comorbidities in the index year of 2006
(n¼ 22,368).
For all analyses, ICD-10 codes were used. The data-
base was searched for the following comorbidity out-
comes in the years 2007 to 2016:
1. Mood disorders (F30-39)
2. Neurotic, stress-related and somatoform disorders
(F40-48)
3. Behavioral syndromes associated with physiological
disturbances and physical factors (F50-59)
4. Back pain (M54.-)
5. Irritable bowel syndrome (K58.-)
Statistical analysis
The occurrence of any of the five listed psychiatric and
pain syndromes in the two groups in the ten subsequent
years (2007–2016) was analyzed with SAS Enterprise
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Guide 7.1. The Chi Square Test was used to evaluate
differences between the investigated groups. Relative
risks for disorders and their confidence intervals (log-
arithmic transformation) in the migraine group com-
pared to the control group were calculated.
Ethics approval
The presented study was approved by the Ethics com-
mittee at the Ludwig-Maximilians-University Munich
(No 17-744 UE). The insurance data was used in an
anonymized way only.
Results
56,597 adolescents at the age of 15 years were insured
by the BARMER insurance company in 2006. 431 of
these adolescents received the consistent diagnosis of
migraine by their physicians, had no other headache
diagnosis (G44.- and/or R51) and none of the pre-
defined psychiatric and pain disorders in 2006 and
therefore met the inclusion criteria for the migraine
group. The control group consisted of 22,368 individ-
uals. For detailed information of inclusion and exclu-
sion process see Figure 1.
A high percentage of the adolescents with migraine
(88.4%) developed at least one of the evaluated addi-
tional disorders in the 10-year follow-up period
(Control group: 69.7%). The overall analysis
(Table 1) showed that patients with a migraine diagno-
sis had a 1.3(1.2;1.3) fold higher risk to develop one or
more of the evaluated additional disorders compared to
persons without a headache diagnosis.
The analysis of the different later additional disor-
ders resulted in the following:
In the course of the disease, patients with migraine
had a 2.1(1.8;2.4) fold higher risk to develop an affec-
tive or mood disorder (ICD 10 diagnoses F30 - F39),
compared to the control group.
Patients diagnosed with migraine developed neurot-
ic, stress-related and somatoform disorders (ICD 10
diagnoses F40 - F48) 1.8(1.6;1.9) fold more often
than persons without a migraine and/or any other
headache diagnosis.
Furthermore the risk for adolescents diagnosed with
migraine for suffering from a subsequent behavioral
syndrome associated with physiological disturbances
and physical factors (ICD 10 diagnoses F50 - F59) in
the course of the disease was 1.8(1.3;2.3) fold higher
compared to the control group.
N = 56 597 in 2006 (with a continuous insurance policy in the 10y
observation period 2006-2016) 
N = 29 649 with a headache diagnosis in the 10y
observation period 
N = 26 948 without any headache diagnosis in the
10y observation period 
N = 5 652 with one or more headache diagnosis
(migraine, TTH, unspecific headache) in 2006 
N = 3956 with TTH and/or unspecific headache
(but without a migraine diagnosis) in 2006 
EXCLUDED 
N = 1 696 with a migraine diagnosis in 2006
(with/without other headache diagnosis) 
N = 1 283 with a migraine diagnosis only (without
TTH/unspecific headache diagnosis) in the 10y
observation period 
N = 778 with (at least) 4 migraine diagnoses in the
10y observation period 
N = 347 with any of the five psychiatric and pain
disorders in 2006 
EXCLUDED
N = 431 
with 4 migraine diagnoses AND without any of the
five psychiatric and pain disorders in 2006 
Control group: N = 22 368 
without any headache diagnosis AND without any
of the five psychiatric and pain disorders in 2006 
N = 4580 with any of the five
psychiatric and pain disorders in 2006  
EXCLUDED
Figure 1. Flow Chart of the study population (N¼number of adolescents).
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Patients with migraine had a 1.6 (1.5;1.7) fold higher
risk to develop back pain (ICD 10 diagnoses M54.-) in
comparison to the control group, and a 1.5 (1.1;2.2)
fold higher risk of having irritable bowel syndrome
(ICD 10 diagnoses K58.-).
The comparison of patients with migraine without
aura (ICD G43.0 in 2006 and three further G43.0 diag-
noses in the subsequent years 2007 to 2016; n¼ 28) to
patients with migraine with aura (ICD G43.1 in 2006
and three further G43.1 diagnoses in the subsequent
years 2007 to 2016; n¼ 34) showed no significant dif-
ference (all p-values >0.05) in developing additional
psychiatric and pain disorders, but sample sizes are
small due to the possibility of unspecific coding (e.g.
ICD G43.9: 75% of all migraine patients in 2006) and
due to the possibility of switching categories in the sub-
sequent years (e.g. G43.0 in 2006 and G43.1 in 2008).
Discussion and conclusion
To our knowledge, our study is the first showing that
adolescents diagnosed with migraine, compared to ado-
lescents without any headache diagnosis, show a signif-
icantly higher risk for developing an additional,
co-morbid disorder (psychiatric disorders/pain syn-
dromes) over the next 10 years in their transition into
adulthood. This vulnerability of adolescent patients
with migraine contributes to the idea that migraine is
a brain state with underlying alterations in the activity
of multiple brain networks (13). Interestingly, other
pain syndromes might also represent a risk for later
psychological disorders, e.g. abdominal pain for the
development of anxiety disorders as described by
Shelby et al. (14). The question if migraine as a brain
state constitutes a specific risk factor for additional
psychological disorders or if chronic pain non-
specifically leads to a higher vulnerability for later dis-
orders is not yet answered.
For clinical care, the result of our study implicates
that the risk profile and vulnerability of young patients
with migraine regarding later additional disorders have
to be considered in the initial medical assessment and
during the clinical course of the disease.
Possible shared mechanisms in neurochemical and
metabolic pathways in the central nervous system
(CNS) support the idea of a correlation and bidirec-
tional influence between migraine and psychiatric dis-
orders (15,16). A review of Dresler et al. showed that
genetic susceptibility for a dysfunction in the 5HT-
Serotonin and D2- Dopamine receptor gene as well
as an imbalance of serotonin neurotransmitters are
shared pathways in the CNS metabolism that can
lead to depressive or pain (migraine/headache) syn-
dromes. Additionally, an imbalance between pro-
inflammatory and anti-inflammatory cytokines in the
hypothalamic-pituitary adrenal (HPA) axis with a
resulting abnormal increased level of pro-
inflammatory cytokines states a possible link between
depression and migraine (16). Those aspects could be
part of an explanation to bidirectional dependence of
the onset of primary headache and mood disorders and
vice versa (15). The complexity of interlinkage between
primary headaches and psychopathological disorders
regarding central nervous system mechanisms implies
that there are multiple causes and potential constella-
tions of reciprocal influence.
Limitations
The first limitation of the presented study is that the
retrospective evaluation of epidemiological data based
on the ICD-diagnoses of treating physicians might be
error-prone as diagnosis depends on the physician’s
experience and the patient’s description of symptoms.
Furthermore, we cannot relate the severity of the
migraine to the seen co-morbidity since there is no
code for that in the ICD 10. Therefore, we only
Table 1. Adolescents with migraine developing the evaluated additional disorders over the 10 year follow up compared to the
control group.







n (%) P value
Relative
risk (CI)
Any of the evaluated additional disorders 381 (88.4%) 15,585 (69.7%) <0.001 1.3 (1.2;1.3)
Mood disorders 138 (32.0%) 3,479 (15.6%) <0.001 2.1 (1.8;2.4)
Neurotic and somatoform disorders 238 (55.2%) 6,973 (31.2%) <0.001 1.8 (1.6;1.9)
Behavioral syndromes (associated with
physiological disturbances)
50 (11.6%) 1,483 (6.6%) <0.001 1.8 (1.3;2.3)
Back pain 313 (72.6%) 10,245 (45.8%) <0.001 1.6 (1.5;1.7)
Irritable bowel syndrome 27 (6.3%) 907 (4.1%) 0.022 1.5 (1.1;2.2)
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included patients with the diagnosis of migraine in at
least three physicians visits. Other headache types, like
TTH or unspecific headaches were excluded as to our
clinical experience these diagnoses seem to be less
stable and more error-prone in adolescence.
Moreover, the analyzed data was obtained from
only one big insurance company. Therefore, data
might not be completely comparable to all patients
with statuary health insurance in Germany.
Nevertheless, the chosen insurance company comprises
11% of German policyholders all over the country and
therefore probably presents a good average of patients
and physicians.
Another limitation is that retrospective data was
analyzed and might contain mistakes e.g. psychiatric
disorders before the starting year (2006), which by
chance were not diagnosed in the index year. Future
prospective studies with standardized diagnostic crite-
ria and patients’ examination by experienced neurolo-
gists and psychiatrists are needed to confirm the higher
risk for developing psychiatric disorders in patients
with primary headache.
Another reflection, and maybe limitation, might be
that patients with migraine might visit physicians more
frequently and therefore have a higher chance to be
detected as psychiatrically ill.
The next limitation is that we selected only five cat-
egories of psychiatric and pain disorders as potential
additional disorders in patients with primary head-
aches. The reason was that these investigated five dis-
orders represent previously described common
comorbidities in patients with migraine and TTH
(7–11). Future studies might include additional disor-
ders especially other psychosomatic and pain syn-
dromes but also vascular disorders as stroke and
cardiac ischemia.
Conclusion
Migraine is one of the most frequent diseases with a
high impact on the quality of life and the everyday life
functioning of affected patients. Therefore, migraine
also influences the financial, social and health system.
In our study, we showed that adolescents with migraine
have a 1.3 fold higher risk to develop later additional
psychiatric or pain disorders compared to adolescents
without any headache diagnosis. This elevated risk for
additional disorders might multiply the negative impact
of migraine on the individual’s well-being and on the
burden for the society. Thus, not only reducing the
frequency and intensity of migraine attacks but also
early assessment of risks for additional disorders is
essential in the care of these patients. Especially the
transition from childhood to adulthood seems to be a
vulnerable phase for this aspect and requires an
increased awareness.
Clinical implications
• 88% of adolescent patients with migraine develop an additional psychiatric or pain disorder in the next ten
years.
• Patients with migraine have a 1.3 fold higher risk to develop at least one additional disorder compared to
the sample without primary headache.
• The most frequent later additional disorders in adolescents with migraine are affective or mood disorders
(ICD 10 diagnoses F30 – F39).
• The development of neurotic, stress-related and somatoform disorders (ICD 10 diagnoses F40 - F48) as
additional disorders is 1.8 fold more often in patients with migraine than in the sample without primary
headache.
• As the risk in adolescents with migraine for developing additional psychiatric disorders later in life is
augmented compared to adolescents without headache, adequate care and early recognition of psycholog-
ical symptoms in the transition from adolescence to adulthood is important.
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